In a study of over 17,000 people, semaglutide, a GLP-1 receptor agonist medication, was found to lower the risk of cardiovascular events like heart attacks and strokes by 20% in people who have pre-existing cardiovascular disease and who are overweight, but do not have Type 2 diabetes
Combining these therapies may amplify their individual benefits by targeting complementary pathways: Enhanced inflammation modulation LDN suppresses cytokines like IL-6, while GLP-1s may reduce broader inflammatory markers and oxidative stress
Real results begin emerging at 5 mg and become significant at 7.5 to 10 mg
Changes in heart rate There have been heart rate changes observed with GLP-1 medications, with some patients experiencing a mild increase in resting heart rate
Quick Answer: You can safely receive a flu shot while taking semaglutide, with no contraindications or required timing adjustments between the two interventions
PlexusDx's Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with no insurance required, making fertility-safe weight loss accessible to men planning families across diverse financial situations